By: Kenny Ng, STJ AMCP Chapter President, PharmD c/o 2017, Kenny Chan, STJ AMCP Chapter President-Elect, PharmD c/o 2017, Davidta…
By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…
By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC - Human immunodeficiency virus (HIV)…
By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…
By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…
By: Maria Sorbera, PharmD Candidate c/o 2013, AMSCOP, LIU - Hepatitis C is the leading cause of chronic liver disease…
By: Steve Soman, Co-Editor-in-Chief - Varicella Zoster Immune Globulin (Varizig®) was approved by the FDA on December 21st of 2012.…
By: Jayoung Park, Pharm.D. Candidate c/o 2013 - Traditionally, human immunodeficiency virus (HIV)-infected patients have generally been excluded from organ…
By: Alisha Kumar, PharmD Candidate c/o 2012 - HIV transmission via organ transplantation is rare in the United States. However,…